Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Private Profits Versus Public Policy - Joel Lexchin

Private Profits Versus Public Policy

The Pharmaceutical Industry and the Canadian State

(Autor)

Buch | Softcover
384 Seiten
2016
University of Toronto Press (Verlag)
978-1-4426-2659-1 (ISBN)
CHF 47,90 inkl. MwSt
The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren’t the interests of the public supposed to supersede the pursuit of private profit?

In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies’ quest for profit.  Joel Lexchin offers a series of recommendations to tip the scale back in the public’s favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years.

Joel Lexchin is a Fellow of the Canadian Academy of Health Sciences. He is a professor in the School of Health Policy and Management at York University and works as an emergency physician at the University Health Network.

Abbreviations

Boxes, Tables and Figures

Introduction: Why do we care about the pharmaceutical industry in Canada?

Chapter 1: (De)regulation through cooperation

Chapter 2: Biased testing, hidden results and the regulation of clinical trials

Chapter 3: Approving new drugs: better or just more?

Chapter 4: Regulating promotion or licensing deception?

Chapter 5: Health Canada and drug safety: how safe are we?

Chapter 6: Is intellectual property a right?

Chapter 7: How revenue is generated: prices, volume, mix and overall spending

Chapter 8: Who gets the value from research and development?

Chapter 9: Canada, the pharmaceutical industry and access to medicines in the Global South

Chapter 10: Courage my friends; ’tis not too late to build a better world

Acknowledgements

Erscheinungsdatum
Zusatzinfo 6 figures
Verlagsort Toronto
Sprache englisch
Maße 154 x 229 mm
Gewicht 590 g
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie
Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Pharmazie
Sozialwissenschaften Politik / Verwaltung Staat / Verwaltung
Sozialwissenschaften Soziologie
Technik
Wirtschaft Volkswirtschaftslehre
ISBN-10 1-4426-2659-3 / 1442626593
ISBN-13 978-1-4426-2659-1 / 9781442626591
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Organisationen steuern, Strukturen schaffen, Prozesse gestalten

von Andreas Gourmelon; Michael Mroß; Sabine Seidel

Buch | Softcover (2024)
Rehm Verlag
CHF 53,20